CompletedPHASE1, PHASE2NCT00633191

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Immunsystem AB
Principal Investigator
Annika Hollsing, MD, PhD
Uppsala Children´s University Hospital
Intervention
Anti-pseudomonas IgY gargle(drug)
Enrollment
14 enrolled
Eligibility
All sexes
Timeline
20032012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00633191 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials